Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H16N2O2 |
Molecular Weight | 244.289 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1C=CN=C1CC2COC3=CC=CC=C3O2
InChI
InChIKey=UXABARREKCJULM-UHFFFAOYSA-N
InChI=1S/C14H16N2O2/c1-2-16-8-7-15-14(16)9-11-10-17-12-5-3-4-6-13(12)18-11/h3-8,11H,2,9-10H2,1H3
Molecular Formula | C14H16N2O2 |
Molecular Weight | 244.289 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20446913
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20446913
Imiloxan is a highly selective alpha2B adrenoceptor antagonist and was developed for depression in the 1980s. In Phase 1 clinical trials imiloxan dosing led to hypersensitivity reactions; the molecule's development was discontinued.
Originator
Sources: http://adisinsight.springer.com/drugs/800007859
Curator's Comment: # Roche Bioscience - UCB
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P18089 Gene ID: 151.0 Gene Symbol: ADRA2B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1970500 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. | 1990 Mar |
|
Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit. | 1993 Jul |
|
Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs. | 2001 Jul |
|
The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. | 2001 Mar |
|
Presynaptic autoregulation of norepinephrine release from the sympathetic nerve fibers in the pineal gland of the domestic pig. Pharmacological characterization of alpha(2)adrenoceptors mediating this process. | 2002 Apr |
|
Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice. | 2002 Jul |
|
1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat. | 2004 |
|
alpha2a adrenoceptors regulate phosphorylation of microtubule-associated protein-2 in cultured cortical neurons. | 2004 |
|
5-HT1B receptors and alpha 2A/2C-adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. | 2004 Jan 26 |
|
5-HT1B receptors, alpha2A/2C- and, to a lesser extent, alpha1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs. | 2004 Jul |
|
Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors. | 2006 Aug 14 |
|
Yohimbine acts as a putative in vivo alpha2A/D-antagonist in the rat prefrontal cortex. | 2006 Jul 24 |
|
Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetine. | 2006 Jun 13 |
|
Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. | 2007 Jan 12 |
|
Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: correlation with alpha(2A/2C)-adrenoceptors. | 2008 May |
|
Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine. | 2009 Apr 17 |
|
Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component. | 2010 Aug |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1352928
Single dose - 500 mg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1970500
Curator's Comment: Imiloxan was identified as a selective alpha 2B ligand of the adrenoceptor
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:39:25 GMT 2023
by
admin
on
Fri Dec 15 16:39:25 GMT 2023
|
Record UNII |
ZJ56PS1DWK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
IMILOXAN
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
DTXSID1045162
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL347695
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
SUB08149MIG
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
C83792
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
C044484
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
ZJ56PS1DWK
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
81167-16-0
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
100000083919
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
5579
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY | |||
|
133621
Created by
admin on Fri Dec 15 16:39:25 GMT 2023 , Edited by admin on Fri Dec 15 16:39:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |